IBB ETF holdings (NASDAQ) - Page 9 | MetaTrader

Open full chart

Overview All holdings Heatmap

Top holdings Market Value Shares Weight %

ARVN Arvinas, Inc. 4.27 M 403.10 K 0.05%

SVRA Savara, Inc. 4.23 M 775.56 K 0.05%

IRWD Ironwood Pharmaceuticals, Inc. 4.12 M 1.17 M 0.05%

PHAT Phathom Pharmaceuticals, Inc. 3.97 M 356.94 K 0.05%

ZVRA Zevra Therapeutics, Inc. 3.86 M 413.74 K 0.05%

CTKB Cytek Biosciences, Inc. 3.80 M 868.73 K 0.05%

MGTX MeiraGTx Holdings plc 3.73 M 430.64 K 0.05%

SPRY ARS Pharmaceuticals, Inc. 3.72 M 463.40 K 0.05%

BIOA BioAge Labs, Inc. 3.70 M 211.36 K 0.05%

SANA Sana Biotechnology, Inc. 3.56 M 1.24 M 0.04%

RIGL Rigel Pharmaceuticals, Inc. 3.54 M 131.03 K 0.04%

ZBIO Zenas Biopharma, Inc. 3.44 M 175.94 K 0.04%

CMPS Compass Pathways plc 3.39 M 612.15 K 0.04%

FULC Fulcrum Therapeutics, Inc. 3.29 M 429.37 K 0.04%

OPK OPKO Health, Inc. 3.29 M 2.88 M 0.04%

SLDB Solid Biosciences, Inc. 3.22 M 446.55 K 0.04%

FDMT 4D Molecular Therapeutics, Inc. 3.15 M 338.74 K 0.04%

PRTA Prothena Corp. plc 3.14 M 323.35 K 0.04%

EBS Emergent BioSolutions, Inc. 3.12 M 376.50 K 0.04%

MYGN Myriad Genetics, Inc. 2.98 M 662.89 K 0.04%

1
...
6
7
8
9
10
11
12
13

News

This Wall Street ‘theme-o-meter’ has a clear message: The artificial-intelligence bull market is back

Equity Outlook Q3 2026: Broadening Earnings Growth Meets Elevated Volatility

SELLAS: Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught Up

It's Not All About AI: Where To Find Other Potential Market Opportunities

Global Markets: Fundamentals Have The Floor

Healthcare Investing: Finding Growth Beyond Pharmaceuticals

SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)

The chip pullback is ushering in a bumpy market. These sectors are the best bets now, according to Morgan Stanley.

The Week The AI Trade Broke, And Why The Data Says 'Rotation,' Not 'Recession'

America At 250: Built On Reinvention, Powered By Innovation

Biotech Is The Rate Cut Trade In Disguise

Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It (NYSEARCA:XLV)